Lumicell launches breast cancer, prostate cancer trials with Lum image-guided system

Lumicell said today that it is launching clinical studies in breast cancer and prostate cancer with its Lum image-guided cancer surgery system.

The breast cancer trial is a pivotal study following an initial training period with surgeons, the Wellesley, Mass.-based company reported, and the prostate cancer study is a first for Lumicell and its technology.

Get the full story at our sister site, Drug Delivery Business News.

The post Lumicell launches breast cancer, prostate cancer trials with Lum image-guided system appeared first on MassDevice.

from MassDevice http://ift.tt/2wGGjTH